Jw Pharmac Total Liabilities
Jw Pharmac total liabilities. Based on the latest financial reports, Jw Pharmac (001060) has total liabilities worth ₩239.83 Billion KRW (≈ $162.53 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jw Pharmac (001060) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jw Pharmac (2000–2025)
Total liabilities of Jw Pharmac from 2000 to 2025. This chart illustrates how Jw Pharmac's total liabilities have evolved over time, based on quarterly financial data. Explore 001060 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Jw Pharmac Competitors by Total Liabilities
The table below lists competitors of Jw Pharmac ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WhiteFiber, Inc. Ordinary Shares
NASDAQ:WYFI
|
USA | $74.02 Million |
|
Haleon PLC
LSE:HLN
|
UK | GBX15.83 Billion |
|
Jiayuan Science and Technology Co.Ltd.
SHE:301117
|
China | CN¥252.70 Million |
|
Zhenhai PetroChem Engineering
SHG:603637
|
China | CN¥265.87 Million |
|
Tidewater Midstream and Infrastructure Ltd
TO:TWM
|
Canada | CA$969.10 Million |
|
Komipharm International Co. Ltd
KQ:041960
|
Korea | ₩61.86 Billion |
|
Roma Green Finance Limited Ordinary Shares
NASDAQ:ROMA
|
USA | $2.84 Million |
|
Wuhan Ligong Guangke Co Ltd
SHE:300557
|
China | CN¥754.18 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Jw Pharmac's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 001060 total assets.
Liquidity & Leverage Metrics
Jw Pharmac Total Liabilities Ratios Explained
Jw Pharmac total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jw Pharmac's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jw Pharmac (2000–2025)
The table below shows the annual total liabilities of Jw Pharmac from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩235.90 Billion ≈ $159.87 Million |
-14.25% |
| 2024-12-31 | ₩275.11 Billion ≈ $186.44 Million |
-27.53% |
| 2023-12-31 | ₩379.60 Billion ≈ $257.25 Million |
-5.62% |
| 2022-12-31 | ₩402.21 Billion ≈ $272.57 Million |
-9.52% |
| 2021-12-31 | ₩444.51 Billion ≈ $301.24 Million |
+30.12% |
| 2020-12-31 | ₩341.62 Billion ≈ $231.51 Million |
-0.44% |
| 2019-12-31 | ₩343.12 Billion ≈ $232.52 Million |
+2.83% |
| 2018-12-31 | ₩333.68 Billion ≈ $226.13 Million |
-7.34% |
| 2017-12-31 | ₩360.10 Billion ≈ $244.03 Million |
-3.91% |
| 2016-12-31 | ₩374.76 Billion ≈ $253.97 Million |
-3.43% |
| 2015-12-31 | ₩388.07 Billion ≈ $262.99 Million |
+4.80% |
| 2014-12-31 | ₩370.29 Billion ≈ $250.94 Million |
-4.72% |
| 2013-12-31 | ₩388.63 Billion ≈ $263.37 Million |
-11.57% |
| 2012-12-31 | ₩439.48 Billion ≈ $297.83 Million |
-11.54% |
| 2011-12-31 | ₩496.84 Billion ≈ $336.70 Million |
+44.69% |
| 2006-12-31 | ₩343.37 Billion ≈ $232.70 Million |
-4.23% |
| 2005-12-31 | ₩358.53 Billion ≈ $242.97 Million |
+6.02% |
| 2004-12-31 | ₩338.16 Billion ≈ $229.17 Million |
+12.95% |
| 2003-12-31 | ₩299.40 Billion ≈ $202.90 Million |
+5.10% |
| 2002-12-31 | ₩284.88 Billion ≈ $193.06 Million |
-3.88% |
| 2001-12-31 | ₩296.37 Billion ≈ $200.84 Million |
-5.01% |
| 2000-12-31 | ₩311.99 Billion ≈ $211.43 Million |
-- |
About Jw Pharmac
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam steri… Read more